Retraction notice to “Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial” [Eur. J. Obstet. Gynecol. Reprod. Biol. 180 (2014) 148–152, (S0301211514003376), (10.1016/j.ejogrb.2014.06.008)];Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 180, Issue 1, 2014, Pages 148-152

  Ismail, Alaa M ^a   Hamed, Ali Hassan ^a   Saso, Srdjan ^b   Thabet, Hossam H ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Induction of ovulation; L carnitine; Oxidative stress; PCOS

Indexed keywords

CARNITINE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PLACEBO; PROGESTERONE; TRIACYLGLYCEROL; CLOMIFENE; FERTILITY PROMOTING AGENT; VITAMIN B COMPLEX;

ABDOMINAL PAIN; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CELL SIZE; CELL STIMULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOMETRIAL THICKNESS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; DRUG COMBINATION; DRUG POTENTIATION; DRUG RESISTANCE; INFERTILITY, FEMALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROCEDURES; YOUNG ADULT;

ADULT; CARNITINE; CLOMIPHENE; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84922448005     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2023.09.028     Document Type: Erratum

References (25)

1. Miyamoto K, Sato EF, Kasahara E, et al. Effect of oxidative stress during repeated ovulation on the structure and functions of the ovary, oocytes, and their mitochondria. Free Radic Biol Med 2010;49(4)674-81 Epub
2. Ringseis R, Eder K, Keller J. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 2012;51 (1):1-18
3. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-82
4. Trivax B, Azziz R. Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 2007;50(1):168-77
5. Clark JH, Markaverich BM. The agonist-antagonist properties of clomiphene. Pharmacol Ther 1981;15:467-519
6. Massai MR, Ziegler DD, Lesobre V. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril 1993;59:1179-86
7. Ahmed Rizk AY, Mohamed Bedaiwy MA, Hesham Al-Inany HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary. Fertil Steril 2005;83(2):367-70
8. Badawy A, Baker EL, Nashar A, El Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the manage-ment of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril 2006;86:647-50
9. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ 2006;332:434-5
10. Krysiak R, Boguslaw O, Gdula-Dymek A, Herman ZS. Update on the management of polycystic ovary syndrome. Pharmacol Rep 2006;58: 614-25
11. Steiber A, Kerner J, Hoppel C. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004;25(5-6):455-73
12. Vanella A, Russo A, Acquaviva R, et al. L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 2000;16:99-104
13. Pillich RT, Scarsella G, Risuleo G. Reduction of apoptosis through the mitochondrial pathway by the administration of acetyl-L-carnitine to mouse fibroblasts in culture. Exp Cell Res 2005;306:1-8
14. Keller JR, Ringseis R, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 2012;51 (1)1-18 10.1007/s00394-011-0284-2 Epub 2011 Dec 2
15. Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod 2008;23(7):1602-6
16. Fujii S, Fukui A, Fukushi Y, Kagiya A, Sato S, Saito Y. The effects of clomiphene citrate on normally ovulatory women. Fertil Steril 1997;68:997-9
17. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. High dose of phytoestrogens can reverse the antiestrogenic effects of clomiphene citrate on the endometrium in patients undergoing intrauterine insemination: a randomized trial. J Soc Gynecol Investig 2004;11:323-8
18. Ohno Y, Fujimoto Y. Endometrial oestrogen and progesterone receptors and their relationship to sonographic appearance of the endometrium. Hum Reprod Update 1998;4:560-4
19. Abdelrazik H, Sharma R, Mahfouz R, Agarwal A. L-Carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos. Fertil Steril 2008;91(2)589-96 Published online
20. Winter BK, Fiskum G, Gallo LL. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995;72:1173-6
21. Kuscu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2009;88:612-7
22. Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 2002;77(6):1128-35
23. Sahlin K. Boosting fat burning with l-carnitine: an old friend coming from shadow. J Physiol 2010;589(7):1509-10
24. Youn-Soo Cha. Effects of L-carnitine on obesity, diabetes, and as anergogenic aid. Asia Pac J Clin Nutr 2008;17(Suppl. 1):306-8
25. Wall BT, Stephens FB, Constantin-Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL. Chronic L-carnitine oral ingestion and carbohydrate increase muscle fuel. J Physiol 2011;589(4):963-73.